Free Trial
NYSEAMERICAN:YCBD

cbdMD (YCBD) Stock Price, News & Analysis

cbdMD logo
$0.36 -0.01 (-2.70%)
(As of 12/20/2024 05:31 PM ET)

About cbdMD Stock (NYSEAMERICAN:YCBD)

Key Stats

Today's Range
$0.32
$0.37
50-Day Range
N/A
52-Week Range
$0.31
$1.73
Volume
175,205 shs
Average Volume
211,233 shs
Market Capitalization
$1.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

cbdMD Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
9th Percentile Overall Score

YCBD MarketRank™: 

cbdMD scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for cbdMD.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of cbdMD is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of cbdMD is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    cbdMD has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.21% of the float of cbdMD has been sold short.
  • Short Interest Ratio / Days to Cover

    cbdMD has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in cbdMD has recently decreased by 6.21%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    cbdMD does not currently pay a dividend.

  • Dividend Growth

    cbdMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.21% of the float of cbdMD has been sold short.
  • Short Interest Ratio / Days to Cover

    cbdMD has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in cbdMD has recently decreased by 6.21%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    cbdMD has a news sentiment score of -0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Business Services companies.
  • Search Interest

    2 people have searched for YCBD on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, cbdMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.95% of the stock of cbdMD is held by insiders.

  • Percentage Held by Institutions

    Only 7.18% of the stock of cbdMD is held by institutions.

  • Read more about cbdMD's insider trading history.
Receive YCBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter.

YCBD Stock News Headlines

cbdMD, Inc. (YCBD-PA)
Cackling Kamala hates this company
Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution.
cbdMD secures trademark, amends agreements
cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript
YCBD Stock Earnings: cbdMD Beats EPS, Beats Revenue for Q3 2024
See More Headlines

YCBD Stock Analysis - Frequently Asked Questions

cbdMD's stock was trading at $0.59 at the beginning of the year. Since then, YCBD stock has decreased by 39.0% and is now trading at $0.36.
View the best growth stocks for 2024 here
.

cbdMD, Inc. (NYSEAMERICAN:YCBD) released its quarterly earnings data on Thursday, December, 16th. The company reported ($3.15) earnings per share for the quarter, missing the consensus estimate of ($2.03) by $1.13. The firm had revenue of $9.79 million for the quarter. cbdMD had a negative net margin of 96.00% and a negative trailing twelve-month return on equity of 350.55%.

cbdMD shares reverse split on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that cbdMD investors own include Village Farms International (VFF), Tilray (TLRY), NVIDIA (NVDA), Roku (ROKU), Organigram (OGI), Bristol-Myers Squibb (BMY) and Bionano Genomics (BNGO).

Company Calendar

Last Earnings
12/16/2021
Today
12/22/2024
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
Consumer Goods
Current Symbol
NYSEAMERICAN:YCBD
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

Net Income
$-22,940,000.00
Pretax Margin
-96.00%

Debt

Sales & Book Value

Annual Sales
$24.16 million
Book Value
$3.16 per share

Miscellaneous

Free Float
3,727,000
Market Cap
$1.35 million
Optionable
Not Optionable
Beta
1.98
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NYSEAMERICAN:YCBD) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners